SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to tame dangerous blood fats
Disease control CompletedThis study tested whether a new injectable drug called olezarsen could lower very high triglyceride levels better than a placebo. It involved 617 adults with severely elevated triglycerides who were already on standard cholesterol medications. Participants received either the dru…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New injection aims to tame dangerous blood fats
Disease control CompletedThis study tested whether a new injectable drug called olezarsen could lower very high triglyceride levels in the blood. It involved 446 adults with severely elevated triglycerides who were already on standard medications. Participants received either olezarsen or a placebo injec…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New shot aims to tame dangerous blood fats
Disease control CompletedThis study tested whether an experimental injection called ARO-APOC3 could safely and effectively lower very high levels of triglycerides, a type of fat in the blood. 229 adults with severe hypertriglyceridemia received either the drug or a placebo shot. The main goal was to see …
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
New shot aims to tame dangerous blood fats
Disease control CompletedThis study tested a new injectable drug called DR10624 to see if it could safely lower very high levels of triglycerides, a type of fat in the blood. It involved 79 adults with severe hypertriglyceridemia, who received either the drug or a placebo (dummy shot) for 12 weeks. The m…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Feb 27, 2026 15:19 UTC